[the_ad id=”9653″]
Graduate Pharmacy Aptitude Test (GPAT) is a national level entrance examination for admission to M. Pharma programmes.
GPAT exam is conducted every year by NTA for admission to M.Pharma program of top pharmacy colleges in India. After passing the GPAT exam, students will get Rs. per month during the M.Pharma programme Scholarship of Rs. 12,400/- is given for 24 months. The Scholarship will be given by UGC from 2023. Earlier, GPAT scholarship was given by AICTE.
Until 2018, the test was conducted by the All India Council for Technical Education (AICTE). NTA has been conducting this test since 2019.
Last 3 years reports of NTA GPAT Notification are mentioned below:
NTA GPAT 2021 NOTICE
| Duration of Online registration and submission of online Application Form for GPAT-2021 | 23 December 2020 to 22 January 2021 |
| Exam Held at | 27 February 2021 |
| Result Decleared | March 19, 2021 |
NTA GPAT 2022 NOTICE
| Duration of Online registration and submission of online Application Form for GPAT-2022 | 16.02.2022 to 17.03.2022 (upto 11:50 P.M.) |
| Exam Held at | 09 April 2022 through the Computer Based Test (CBT) mode from 09:00 A.M. to 12 Noon. |
| Result Decleared | 20th May 2022 |
NTA GPAT 2023 NOTICE
| Duration of Online registration and submission of online Application Form for GPAT-2023 | 13.02.2023 to 06.03.2023 (upto 05:00 P.M.) |
| Exam Held at | 22 May 2023 Shift 1: 09:00 A.M. to 12 Noon Shift 2: 02:30 P.M. to 05:30 P.M |
| Result Decleared | 01st July, 2023 |
NTA GPAT 2024 Expected Notification
| Duration of Online registration and submission of online Application Form for GPAT-2023 | 1st Week of March to 2nd Week of April 2024 |
| Exam Held at |
4th week of May or 1st June 2024 Shift 1: 09:00 A.M. to 12 Noon |
| Declearation of Result | 1st Week of July, 2024 |
<<<<<<<<<<<<JOIN US>>>>>>>>>>>>>>>>
| Subscribe our PHARMACY INDIA Youtube Channel for more Pharma Updates | Click Here |
| Follow us on Instagram | Click Here |
| Download PHARMACY INDIA MOBILE APP from Google Play Store | Click Here |
| Follow us on LinkedIn | Click Here |
